SYNTHESIS
December 1998
1729
Nitration of Camptothecin (1) with a Combination of Two Differ-
ent Nitrates in Sulfuric Acid; Typical Procedure:
1H NMR: δ = 1.05 (3H, t, J = 7.40 Hz, C19-methyl protons), 1.92 (2H,
m, C18-methylene protons), 3.82 (1H, s, C20-OH), 5.40 (2H, s, C5-
methylene protons), 5.55 (2H, dd, J = 14.21, 14.21 Hz, C17-methyl-
ene protons), 7.70 (1H, s, C14-H), 7.92 (1H, t, J = 8.40 Hz, C11-H),
8.48 (1H, d, J = 8.35 Hz, C10-H), 8.55 (1H, d, J = 8.35 Hz, C12-H),
9.36 (1H, s, C7-H).
Camptothecin (1) (4.0 g, 0.0115 mol) was added to concd H2SO4
(100 mL) in a 250-mL three-necked flask. The suspension was stirred
with a mechanical stirrer until the most of camptothecin went to solu-
tion (~15 to 30 min). To this solution KNO3 (2.32 g, 0.0230 mol) and
Cu(NO3)2•2.5 H2O (2.67 g, 0.0115 mol) were added all at once. The
mixture was stirred at r.t. for 72 h and poured onto ice-water
(1500 mL) while stirring. The yellow suspension in water was ex-
tracted with CH2Cl2 (4 × 500 mL). The combined extracts were dried
(anhyd Na2SO4, 8 h). The Na2SO4 was removed by filtration. After
removal of CH2Cl2 by a rotary evaporator, the crude reaction products
were obtained as yellow powders, containing 9NC (24%), 12NC
(50%), unreacted camptothecin (6%), and other byproducts (20%).
The results of HPLC analyses for all these nitration reactions are
shown in Table 3.
MS: m/z (%) = 393 (M+, 100), 364 (M – C2H5, 35), 349 (48), 334 (25),
320 (25), 293 (35), 274 (8), 262 (8), 246 (15), 234 (6), 218 (20), 205
(8), 190 (9), 177 (5), 164 (3), 151 (3), 137 (5), 123 (4), 109 (5), 95 (5),
75 (3), 60 (23).
HRMS: calcd for C20H15N3O6 393.0960. Found 393.0961.
HPLC Procedure for Purity Analysis of 9-Nitrocamptothecin (4):
Instrumentation: The HPLC system consisted of a Beckman 421 con-
troller with two 110A pumps and a 2 mL injection loop. The UV de-
tector was a SPD-110AV model (Shimadzu, Kyoto, Japan). The
HPLC detector was set to monitor the UV absorbance at 220 nm. The
integrating software used for the analyses was EZChrome (Shimadzu,
Japan) and FLO-ONE\beta (Radiomatic Instruments, Meridian, CT).
A C-8 Microsorb was from Rainin Instruments (Woburn, MA).
HPLC analysis: Reverse phase HPLC analysis of the samples was
carried out by using a MeCN/HOAc/H2O mobile phase system. Anal-
yses were carried out at r.t. with a flow rate 1 mL/min. The solution
with a concentration of approximately 0.1 mg/mL of 9NC in MeCN
was prepared by dissolving it in the solvent. A 300 µL portion of this
solution was taken and added to 700 µL solution of 0.1% HOAc/H2O.
After shaking for ~10 s, 100 µL of this solution was injected through
a 2 mL loop onto column and chromatographed with 70% H2O with
0.1% HOAc and 30% MeCN as the mobile phase for the period of
first 5 min, and then the gradient of the mobile phase was program-
matically increased to 100% MeCN over a period of 4 min. A com-
plete HPLC spectrum was obtained in 15 min. The purity of 9NC was
determined by measuring the UV peak areas at 254 nm and calculat-
ing the percentage associated with the 9NC peak. The retention time
of 9-nitrocamptothecin under these conditions is approximately
6.5 min.
Nitration of Camptothecin (1) with a Combination of Three or
More Inorganic Nitrates in Sulfuric Acid; Typical Procedure:
Camptothecin (1) (4.0 g, 0.0115 mol) was suspended in concd H2SO4
(100 mL) in a 250-mL round-bottomed flask equipped with a me-
chanical stirrer. After stirring for ~30 min (until camptothecin was
almost dissolved), a combination of KNO3 (1.16 g, 0.0115 mol),
TlNO3 (3.10 g, 0.0116 mol), and Cu(NO3)2•2.5 H2O (2.67 g.
0.0115 mol) was added all at once. The mixture was stirred at r.t. for
72 h and then poured onto ice-water (1500 mL) while stirring. The
yellow suspension was extracted with CH2Cl2 (4 × 500 mL). The
combined extracts were dried (anhyd Na2SO4), filtered, and evaporat-
ed. The crude reaction products were obtained as yellow powders,
containing 9NC (25%), 12NC (44%), unreacted camptothecin (10%),
and other byproducts (21%). The results of HPLC analyses for all
these nitration reactions are shown in Table 4.
Nitration of Camptothecin (1) with Different Ratios of a Combi-
nation of KNO3 and TlNO3 in Sulfuric Acid; Typical Procedure:
Camptothecin (1) (6.0 g, 0.0172 mol) was added to concd H2SO4
(100 mL) in a 250-mL three-necked flask equipped with a mechanical
stirrer. After stirring at r.t. for ~30 min, a combination of KNO3
(1.74 g, 0.0172 mol) and TlNO3 (4.58 g, 0.0172 mol) was added all at
once. The mixture was stirred at r.t. for 72 h and then poured onto ice-
water (1500 mL) while stirring. The yellow suspension was extracted
with CH2Cl2 (4 × 500 mL). The combined extracts were dried (anhyd
Na2SO4, 8 h). After removal of CH2Cl2 by a rotary evaporator, the
crude reaction products were obtained as yellow powders, containing
9NC (26%), 12NC (49%), unreacted camptothecin (11%), and other
byproducts (14%). The results of HPLC analyses for all these reaction
are shown in Table 5.
HPLC Procedure for the Analyses of Crude Reaction Products:
The HPLC procedure for the analyses of crude nitration reaction
products is the same as the one for the purity analysis of 9-nitrocamp-
tothecin.
Financial support from the Stehlin Foundation for Cancer Research
and The Friends of The Stehlin Foundation is gratefully acknowl-
edged.
(1) Wall, M. E.; Wani, M. C.; Cook, C. E.; Palmer, K. H.; McPhail,
A. T.; Sim, G. A. J. Am. Chem. Soc. 1966, 88, 3888.
(2) Kingsburg, W. D.; Boehm, L. C.; Jakas, D. R.; Holden, K. G.;
Hecht, S. M.; Glagher, G.; Caranfa, M. J.; McCabe, F. L.; Fau-
cette, L. F.; Johnson, R. K.; Hertzberg, R. P. J. Med. Chem.
1991, 34, 98.
Nitration of Camptothecin (1) with a Combination of KNO3 and
TlNO3 in Various Volumes of Sulfuric Acid:
The general procedure was the same as above. The results was shown
in Table 6.
9-Nitrocamptothecin (4):
(3) Sawada, S.; Matsuoka, S.; Nokata, K.; Nagata, H.; Furuta, T.;
Yokokura, T., Miyasaka,T. Chem. Pharm. Bull. 1991, 39, 3183.
(4) Wani, M. C.; Nicholas, A. W.; Wall, M. E. J. Med. Chem. 1986,
29, 2358.
(5) Giovanella, B. C.; Stehlin, J. S.; Wall, M. E.; Wani, M. C.; Ni-
cholas, A. W.; Liu, L. F.; Silber, R.; Potmesil, M. Sciences
(N.Y. Acad. Sci.) 1989, 246, 1046.
(6) Kawato, Y.; Furuta, T.; Aonuma, M.; Ysuoka, M.; Yokokura,
T.; Matsumoto, K. Cancer Chemother. Pharmacol. 1991, 28,
192.
(7) Houghton, P. J.; Cheshire, P. J.; Myers, L.; Stewart, C. F.; Syn-
old, T. W.; Houghton, J. A. Cancer Chemother. Pharmacol.
1992, 31, 229.
Camptothecin (1) (4.0 g, 0.0115 mol) was added to concd H2SO4
(300 mL) in a 1000-mL three-necked flask. After stirring for ~15 min,
KNO3 (2.0 g, 0.0198 mol) and TlNO3 (5.0 g, 0.0188 mol) were added
all at once. The mixture was stirred at r.t. for 72 h and then poured
onto ice-water (3500 mL) while stirring. The yellow suspension was
extracted with CH2Cl2 (1 × 1500 mL and 2 × 900 mL). The combined
extracts were dried (anhyd Na2SO4, 8 h). After filtration, the solvents
were removed by a rotary evaporator. The residue was chromato-
graphically separated. The crude 9-nitrocamptothecin was allowed to
reflux in abs EtOH for 2–4 h. Pure product 4 was obtained by repre-
cipitation from EtOH to give bright yellow crystals; yield: 20%; mp
268°C.